The risk of PML from natalizumab
- PMID: 30784548
- DOI: 10.1016/S1474-4422(19)30021-3
The risk of PML from natalizumab
Comment in
-
The risk of PML from natalizumab - Authors' reply.Lancet Neurol. 2019 Mar;18(3):230-231. doi: 10.1016/S1474-4422(19)30022-5. Epub 2019 Feb 12. Lancet Neurol. 2019. PMID: 30784549 No abstract available.
Comment on
-
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.Lancet Neurol. 2017 Nov;16(11):925-933. doi: 10.1016/S1474-4422(17)30282-X. Epub 2017 Sep 29. Lancet Neurol. 2017. PMID: 28969984
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
